Four years ago, after entering what is known as menopause, I began to suffer from asteatotic eczema caused by dryness every ...

A retrospective study of 313 patients found that baseline renal impairment doubled the risk of rash during gemcitabine plus ...

For those in a hurry—a concise version summarizing only the main points is available on the blog.A rash that appeared after ...

Roivant's brepocitinib (Lisraya) succeeded in two non-infectious uveitis trials, with plans to file for approval in H1 2027.

AstraZeneca has submitted applications in the U.S. and China seeking first-line use, with both regulators granting ...

Identify R&D opportunities through pipeline benchmarking, clinical-stage analysis, unmet needs, collaborations, licensing, mergers and acquisitions.Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Atopic ...

It seems we cannot go a week without hearing about some new health or beauty craze, usually on social media sites that cater ...

The approval only covers a narrow group of rectal cancer patients, but for them it may rewrite what treatment looks like.

Researchers combined self-reported experiences from thousands of patients with health and genetic data to investigate ...

Local law enforcement officials are asking motorists to be more alerts on the road following a rash of crashes involving ...

A 2026 narrative review finds that most myeloid-directed cancer programs show target activity without proving immune ...

Oct 2 (Reuters) - Biogen said on Friday its experimental drug showed durable improvement in skin symptoms among patients with a type of autoimmune disease in a mid-stage study. Here are some details: ...